You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 279 No. 9, March 4, 1998 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Medical News & Perspectives
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Studies Reveal Early Impact of HIV Infection, Effects of Treatment

Joan Stephenson, PhD

JAMA. 1998;279:641-642.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

NEW STUDIES about events early in the course of infection with the human immunodeficiency virus (HIV) may have important implications in treating the infection, namely, when clinicians should institute aggressive anti-HIV therapy. Results of these studies and other findings, including information about the emergence of unusual adverse effects in patients treated with protease inhibitors and the earliest evidence about when HIV infection appeared in the human population, were among the discoveries reported at the Fifth Conference on Retroviruses and Opportunistic Infections held in Chicago, Ill, last month.


How Crucial is Early Treatment?

Initiating treatment with a potent combination of antiretroviral drugs as soon as possible after infection with HIV may be critical to preserving a key element of the immune system, said Bruce D. Walker, MD, of Massachusetts General Hospital, Charlestown. New studies described by Walker suggest that for most HIV-infected people, virus-specific helper T cells are . . . [Full Text of this Article]



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Oral Treatment with Trimethoprim-Sulfamethoxazole and Zidovudine Suppresses Murine Accessory Cell-Dependent Immune Responses
Freund et al.
Toxicol Sci 2000;55:335-342.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.